The Asia-Pacific nuclear medicine market was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028. The market is ...

In what is believed to be a world-first study, researchers from the University of Adelaide's Australian Dysautonomia and ...

Since the donation of a SPECT camera by the International Atomic Energy Agency (IAEA), a busy hospital in Brazil’s city of Niteroi has doubled its capacity to perform heart scans, expanding access to ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Activation imaging using neutron-irradiated gold nanoparticles enables visualization of drug distribution in mice for several ...

UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...

GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular ...

Single photon emission computed tomography (SPECT) is a nuclear medicine technique that uses gamma rays to provide 3D information about the inside of the body and examine organ function. "In ...

A brain SPECT creates a detailed ... circulation in POTS even while patients are lying down using an imaging technique which is widely accessible to doctors," said Dr. Seeley.

GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.